Elixinol Wellness Limited
ELLXF
$0.01
$0.01248.78%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.70% | 7.65% | 69.98% | 73.96% | 93.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.03% | 7.97% | 69.98% | 73.96% | 93.35% |
| Cost of Revenue | 9.93% | 7.88% | 69.12% | 73.05% | 129.80% |
| Gross Profit | 10.21% | 8.15% | 71.57% | 75.57% | 48.67% |
| SG&A Expenses | 11.37% | 9.28% | 0.28% | 2.63% | -10.43% |
| Depreciation & Amortization | -7.46% | -9.23% | 51.61% | 55.23% | 100.57% |
| Other Operating Expenses | 156.03% | 151.23% | 280.49% | 284.53% | 142.18% |
| Total Operating Expenses | 11.70% | 9.61% | 38.72% | 41.96% | 40.23% |
| Operating Income | -15.86% | -13.70% | 14.56% | 12.56% | 16.79% |
| Income Before Tax | -9.14% | -7.09% | 37.82% | 36.36% | 19.93% |
| Income Tax Expenses | -- | -- | -390,000.00% | -401,000.00% | -57.14% |
| Earnings from Continuing Operations | -9.10% | -7.05% | 125.15% | 125.74% | 19.94% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.10% | -7.05% | 125.15% | 125.74% | 19.94% |
| EBIT | -15.86% | -13.70% | 14.56% | 12.56% | 16.79% |
| EBITDA | -27.52% | -25.12% | 21.96% | 20.15% | 27.29% |
| EPS Basic | 38.36% | 39.73% | 109.89% | 110.38% | 71.03% |
| Normalized Basic EPS | 28.89% | 31.11% | 64.56% | 63.29% | 68.75% |
| EPS Diluted | 38.36% | 39.73% | 109.84% | 110.33% | 71.03% |
| Normalized Diluted EPS | 28.89% | 31.11% | 64.56% | 63.29% | 68.75% |
| Average Basic Shares Outstanding | 78.10% | 78.10% | 151.00% | 151.00% | 177.18% |
| Average Diluted Shares Outstanding | 78.10% | 78.10% | 151.00% | 151.00% | 177.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |